Novartis AG Total Non-Operating Income/Expense 2010-2025 | NVS
Novartis AG total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.916B, a 15.66% increase year-over-year.
- Novartis AG annual total non-operating income/expense for 2024 was $-0.904B, a 39.94% increase from 2023.
- Novartis AG annual total non-operating income/expense for 2023 was $-0.646B, a 15.99% decline from 2022.
- Novartis AG annual total non-operating income/expense for 2022 was $-0.769B, a 105.32% decline from 2021.